3-(4-bromophenyl)-3-hydroxy-1-phenylprop-2-en-1-one, 95%, 500mg

Óxido de antimonio (III), mínimo 99 %, pa, 1 kg, envase de plástico.

1-(AZETIDIN-3-YL)-3-FLUOROAZETIDINE OXALATE, 95.0%, 500mg

Phenol, 4,4'-(4,5,6,7-tetrabromo-1,1-dioxido-3H-2,1-benzoxathiol-3-ylidene)bis[2-iodo-6-nitro- (9CI), 250mg

7-Bromo-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one, 95.0%, 250mg

Tetrachlorophthalic acid; >98%, 95.0%, 100g

1-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)ethanone, 95.0%, 10g

2-Bromoethyl methyl ether (stabilised with Potassium Carbonate), 99.0%, 25g

1-(3,4-Dimethoxyphenyl)-2-phenylethan-1-one, 95+%, 250mg

Hilo de platino 99,99% 0,25 mm diámetro 25 cm

2-Chloro-4,6-dimethylpyridin-3-amine, 95.0%, 250mg

(11bS)-3,5-Bis(3,5-di-tert-butylbenzyl)-4,5-dihydro-3H-dinaphtho[2,1-d:1',2'-f][1,3,2]diazaphosphepine 4-oxide, 98%, 50mg

1-methyl-5-phenyl-1H-pyrrole-2-carboxylic acid, 95.0%, 250mg